By processing multiple scRNA-seq datasets across three murine GB cell lines (CT-2A, GL261, and 005) (Table S2) with different genetic and phenotypic profiles (Table S3) and analyzing GB tumor cells, we confirmed a trend of low Il12a/b gene expression in the TME and the tumor cells (Figures S1E and S1F). This evidence concerns the gene IL12A and neoplasm.